Seurat Therapeutics, Inc
Seurat Therapeutics, Inc., based in Chicago, Illinois, is a privately held biopharmaceutical company dedicated to translating neurological research breakthroughs into innovative medications aimed at treating debilitating nervous system disorders. Their focus includes migraine headaches, fibromyalgia, chronic pain syndromes, and epileptic seizure disorders.
The company's unique name pays homage to the iconic artist George-Pierre Seurat, whose own experiences with migraines inspired his distinctive pointillistic style. This connection highlights the relationship between neurological conditions and visual distortions, often referred to as the Seurat effect by neurologists.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.